| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, February 2002, p. 793-802, Vol. 82, No. 2
and
*Institut für Molekulare Medizin und Zellforschung,
Albert-Ludwigs-Universität, D-79104 Freiburg, Germany; and
Howard Hughes Medical Institute, Laboratory of Molecular
Biology and Biochemistry, Rockefeller University, New York, New York
10021 USA
| |
ABSTRACT |
|---|
|
|
|---|
Suramin, a polysulfonated naphthylurea, is under
investigation for the treatment of several cancers. It interferes with
signal transduction through Gs, Gi, and
Go, but structural and kinetic aspects of the molecular
mechanism are not well understood. Here, we have investigated the
influence of suramin on coupling of bovine rhodopsin to Gt,
where G-protein activation and receptor structure can be monitored by
spectroscopic in vitro assays. Gt fluorescence changes in
response to rhodopsin-catalyzed nucleotide exchange reveal that suramin
inhibits Gt activation by slowing down the rate of complex
formation between metarhodopsin-II and Gt. The metarhodopsin-I/-II photoproduct equilibrium, GTPase activity, and
nucleotide uptake by Gt are unaffected. Attenuated total
reflection Fourier transform infrared spectroscopy shows that the
structure of rhodopsin, metarhodopsin-II, and the metarhodopsin-II
Gt complex is also not altered. Instead, suramin
dissociates Gt from disk membranes in the dark, whereas
metarhodopsin-II Gt complexes are stable. Förster
resonance energy transfer suggests a suramin-binding site near
Trp207 on the Gt
subunit (Kd
~0.5 µM). The kinetic analyses and the structural data are
consistent with a specific perturbation by suramin of the membrane
attachment site on Gt
. Disruption of membrane anchoring
may contribute to some of the effects of suramin exerted on other
G-proteins.
| |
INTRODUCTION |
|---|
|
|
|---|
Suramin, a hexasulfonated polyaromatic
naphthylurea (1.4 kDa), is under study for therapeutic activity in
phase II trials in the treatment of several cancers (Mirza et al.,
1997
; Dawson et al., 1998
; Dreicer et al., 1999
). It exhibits
antiangiogenetic and antiproliferative activity (Firsching et al.,
1995
) by interfering with the binding of several growth factors to
their receptors (Coffey et al., 1987
). These properties can be enhanced
in suramin analogs (Gagliardi et al., 1998
). However, adverse effects
of suramin are dose-limiting (Chaudhry et al., 1996
), and the molecular basis of its action is not well understood. The function of several cellular signaling proteins, such as protein-tyrosine phosphatases (Zhang et al., 1998
) and protein kinase C (Khaled et al., 1995
) is
perturbed, and recent interest in suramin focuses on its ability to
interfere also with signaling through G-protein-coupled receptors (GPCRs). GPCRs are heptahelical transmembrane proteins that respond to
extracellular signals, such as binding of a hormone or a
neurotransmitter, by catalyzing GDP/GTP exchange in cytosolic
guanosine-nucleotide-binding proteins (G-proteins) (for reviews see Ji
et al., 1998
; Gether, 2000
). Suramin has been shown to uncouple
2- and
2-adrenergic receptors from Gi and Gs,
respectively (Huang et al., 1990
). It has also been shown that suramin
inhibits activation of pertussis-toxin-sensitive G-proteins by
-opioid receptors in NG 108-15 cell membranes, whereas nucleotide
exchange induced by serum factors binding to an unidentified receptor
was not affected (Butler et al., 1988
). Based on these initial
observations, the potential of suramin analogs to interfere with
signaling by different receptor G-protein tandems has been investigated
systematically. A suramin analog has been described that uncouples
A1 adenosine and D2
dopamine receptors from
Gi/Go with different
specificity (Beindl et al., 1996
; Waldhoer et al., 1998
), and a number
of analogs have been synthesized that act as subtype-specific G-protein
inhibitors (Hohenegger et al., 1998
; Waldhoer et al., 1998
). Such
studies emphasize the role of G-proteins as potential drug targets
(Höller et al., 1999
). However, details of the molecular
mechanism by which suramin affects structural and kinetic parameters of
receptor G-protein interactions remain to be elucidated. In an attempt to exploit a well characterized in vitro model system for GPCR signaling, we have investigated the effect of suramin on activation of
transducin (Gt) by the bovine photoreceptor
rhodopsin. For this system, biophysical assays for conformational
changes of the receptor, Gt binding, and
Gt activation are available. Based on the
homology of class I (rhodopsin-like) GPCRs, a study of the action of
suramin on rhodopsin Gt interactions helps to
identify molecular mechanisms by which the drug may affect signaling in related systems.
Rhodopsin is a prototypical GPCR (Helmreich and Hofmann, 1996
; Menon et
al., 2001
; Okada et al., 2001
) and the only one for which a crystal
structure has been solved (Palczewski et al., 2000
). Rhodopsin is
unique as it is not ligand-activated. Instead, 11-cis-retinal is covalently attached to
Lys296 of the apoprotein via a protonated Schiff
base (Oseroff and Callender, 1974
). Photoisomerization to
all-trans-retinal promotes structural changes involving
helix-helix interactions and rigid body movements (Farrens et al.,
1996
; Han et al., 1996
; Sheikh et al., 1996
). As a consequence,
cytosolic domains of the active metarhodopsin-II (MII) state bind
Gt and catalyze GDP/GTP exchange. Signaling by the rhodopsin Gt tandem has been optimized for
maximal light sensitivity, which implies minimization of dark noise
(Birge and Barlow, 1995
; Rieke and Baylor, 1996
). Correspondingly,
basal nucleotide exchange, typical of other G-proteins, is negligible
in Gt. The unique features of rhodopsin and
Gt suggest that interference with receptor
coupling is the predominant mode of action by which a pharmacologically active substance may modulate Gt activation.
Other potential perturbations such as interference with basal G-protein
activation or competition with agonist binding are not expected to
contribute to the readout from this model system.
We have applied fluorescence spectroscopy to analyze binding of suramin
to Gt
and to monitor rhodopsin-catalyzed
Gt activation. By attenuated total reflection
(ATR) Fourier transform infrared (FTIR) spectroscopy we have
investigated the influence of suramin on the structure of rhodopsin and
the MIIGt complex. We show that suramin binds to
Gt
but does not affect either GTP uptake or
GTPase activity. Likewise, structural changes during rhodopsin activation are not influenced. Instead, the rate of
MIIGt formation is reduced by a dose-dependent
inhibition of membrane anchoring of Gt. In
addition to inferences on receptor G-protein coupling in nonvisual
signaling, the data are relevant for the molecular characterization of
side effects on vision in patients receiving suramin treatment. A
variety of ocular symptoms have been described (for example, Hemady et
al., 1996
).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Purification of rhodopsin and transducin
Preparation of washed membranes from bovine rod outer segments
(ROSs) was carried out as described (Papermaster, 1982
) with minor
modifications. Gt was purified from illuminated,
osmotically shocked ROSs by successive washes and hexyl agarose
chromatography (Kühn, 1980
; Fung et al., 1981
).
Gt was eluted with 300 mM NaCl in buffer solution
(10 mM sodium phosphate, pH 7.2, 2 mM MgCl2, 1 mM
dithiothreitol (DTT), 0.1 mM phenylmethylsulfonyl fluoride). Pooled
fractions were diluted with buffer to a final concentration of 100 mM
NaCl. Gt
and Gt
were isolated from Gt (prepared from bovine
retinas, Lawson, Lincoln, NE) according to published methods (Shichi et
al., 1984
) using a Hitachi LC-organizer high-performance liquid
chromatography system with 1 ml of Hi-Trap Blue Sepharose column
(Amersham Pharmacia Biotech, Piscataway, NJ). The proteins were
eluted with a 0-2 M NaCl gradient. Protein concentrations were
determined using the Bio-Rad protein assay reagent according to
manufacturer's instructions. The subunits were stored at
20°C in a
50% glycerol buffer until use.
ATR-FTIR spectroscopy
Disk membranes (1-2 nmol of rhodopsin) were dried under
nitrogen on a trapezoidal (45°) internal reflection element (IRE) made of ZnSe (3.5 cm2) mounted in a Bruker A737
temperature-controlled dialysis-coupled (10,000 MW cutoff) ATR cell.
Under these conditions, membrane stacks of at least 50 layers are
expected to form, when the surface coverage by rhodopsin in disk
membranes is estimated from the crystal structure (Palczewski et al.,
2000
) to be ~1500 Å2. Thus, more than 98% of
rhodopsin is excluded from possible denaturing influences of the ZnSe
surface and the functionality (normal light-dependent MII formation and
Gt activation) of the resulting matrix of
immobilized disk membranes has been demonstrated (Fahmy, 1998
).
After addition of Gt (0.5-1 ml, 4-6 µM, 10 mM sodium phosphate buffer, pH 7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT) to the sample compartment, its association with disk membranes was monitored in a vector 22 FTIR spectrophotometer (Bruker, Karlsruhe, Germany). GTP, suramin, and heparin were purchased from Sigma-Aldrich (Milwaukee, WI) and used without further purification. Dissociation of Gt from disk membranes was induced by addition of the appropriate amounts of these substances to the dialysis reservoir of the ATR cell. Subsequent spectral changes were measured as the difference between the absorption (calculated from 256 interferograms) at a given time after and the absorption immediately before the addition of either substance. Experiments were carried out at 17°C. Light-induced IR absorption changes during metarhodopsin II (MII) formation in the absence of Gt were measured at 10°C (10 mM sodium phosphate buffer, pH 5, 100 mM NaCl, 30 s illumination with 150-W projector light using a GG 495 filter from Schott, (Mainz, Germany).
Fluorescence measurements
GTP-induced changes of tryptophan fluorescence from
Gt were recorded with a home-built instrument,
using fiber optics attached to a temperature-controlled cuvette holder
for excitation and emission in 90° geometry. Excitation was achieved
with UV light from a deuterium lamp equipped with an interference
filter transmitting 290-310-nm light (300FS10-25, L.O.T. Oriel,
Darmstadt, Germany). Emitted light (
max = 345 nm) was detected by a photomultiplier after transmission through a
335-nm cutoff filter (WG 335 Schott). Integration time of the
fluorescence signals was 4 s and the reaction mixture was
continuously stirred by a magnetic stir bar in a quartz cuvette. A
suspension of disk membranes in buffer containing 1-2 µM
Gt was photoactivated 5 min before starting
fluorescence recordings. The reaction mixture (0.8 ml) was
thermostatted to 27°C.
FRET from suramin to Gt
was measured in a Spex
Fluorolog 3-11
3 spectrofluorometer equipped with a 450-W xenon arc
lamp. Excitation was at 295 nm, and emission was recorded between 315 and 450 nm. The fluorescence spectra were recorded in 10 mM Tris buffer
(pH 7.2), 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, 5 µM GDP, and 0.01% dodecyl maltoside.
Data analysis
Kinetic fluorescence data were fitted by numerical integration
of rate equations using the Newton method. In a two-step reaction model, the time derivative of the concentration of the GTP-bound state
of Gt was assumed to depend on the rate constants
k1 and k2, describing formation of
Gt
(GTP) from Gt
(GDP)
and GTP (catalyzed by MII) and decay of
Gt
(GTP) to Gt
(GDP) and Pi by intrinsic GTPase activity of
Gt
, respectively:
|
(1) |
|
(GDP).
In a more realistic three-step model, the formation of the
MIIGt complex from MII and
Gt(GDP) and uptake of GTP (followed by immediate
dissociation of the MIIGt complex) was described by the rate constants kc and
ku, respectively:
|
(2) |
|
|
(3) |
|
(GDP) in the three-step model. This leads to
a superior simulation when MIIGt formation
becomes rate limiting.
Data on FRET from Gt
to suramin were analyzed
to determine the fraction f(Gt
) of
free Gt
in the presence of varying amounts of
suramin according to Eq. 4:
|
(4) |
1 cm
1 at 295 and 343 nm, respectively. Absorption and fluorescence spectra of suramin have
been published (Mély et al., 1997| |
RESULTS |
|---|
|
|
|---|
Fluorescence monitoring of Gt activation
To investigate the action of suramin on receptor-dependent
G-protein signaling, we have designed experiments using the bovine photoreceptor rhodopsin and Gt as a model system.
Rhodopsin-catalyzed nucleotide exchange and GTP hydrolysis by
Gt were monitored with a real-time
Gt activation assay (Fahmy and Sakmar, 1993
;
Ernst et al., 2000
) based on intrinsic G-protein fluorescence
(Higashijima et al., 1987
). The fluorescence increases of
Trp207 of Gt
(GTP) or
Gt
(GTP
S) versus
Gt
(GDP) (Faurobert et al., 1993
) allow the
observation of nucleotide uptake and hydrolysis during multiple cycles
of Gt activation. Fig.
1 shows fluorescence recordings from
Gt in a suspension of light-activated disk
membranes. Repeated addition of GTP caused transient fluorescence
increases corresponding to the increase of
[Gt
(GTP)] followed by a decrease due to
GTPase activity of Gt
. The traces evidence the
catalytical nature of the Gt turnover and the
stability of rhodopsin Gt interactions during the
time of the experiment. Addition of a saturating amount of the
nonhydrolyzable GTP analog GTP
S caused a persistent fluorescence
increase. The decrease in fluorescence upon further addition of GTP
S
as well as the fluorescence signal reached at the end of GTP-induced
signals scaled precisely with the corresponding dilution of the
reaction buffer.
|
The described assay allows an accurate evaluation of the kinetics of
rhodopsin Gt coupling. The peak height and width
of the GTP-induced transients is determined by the apparent rate of the rising and falling phase of [Gt
(GTP)]. The
peak height (normalized to the GTP
S-induced signal) decreased
whereas the peak width increased as a function of suramin
concentration. This indicates that suramin caused an increase of the
apparent fluorescence rise time. In principle, the effect of suramin
may be accounted for by denaturing Gt or
rhodopsin. However, the more thorough quantitative analysis of reaction
kinetics as well as spectroscopic data, presented below, strongly
suggest that the data in Fig. 1 must be explained by a specific
inhibitory effect of suramin on the MII-dependent formation of
Gt
(GTP).
For a given rate of GTP hydrolysis, the area under the transient
fluorescence signal is a measure of the amount of GTP hydrolyzed. Because identical aliquots of GTP were injected in all experiments, the
peak area is not expected to depend on the presence of suramin if the
drug exclusively influenced the formation of
MIIGt. Integration intervals and baseline
positions for GTP-induced peaks are represented by the length and
vertical position, respectively, of the bars in Fig. 1. In trace
A, the baseline was determined by the fluorescence level at
the end of the transient. In traces B-D,
baselines were adjusted to obtain identical normalized peak areas as in
trace A. The correspondence of normalized areas under
GTP-induced signals is exemplified in panel C, where the
GTP-induced transient has been replotted in a scale in which the
GTP
S-induced signal (shown to the right) matches that in
A. Evidently, the criterion of invariant peak areas yields
excellent agreement with the measured traces. Thus, an effect of
suramin on GTPase activity is negligible within the accuracy of the experiment.
Estimates of the apparent rate constants
k1 and
k2 for GTP uptake and hydrolysis,
respectively, can be obtained in the realm of a two-step reaction model
described by Eq. 1. The larger
k1/k2, the higher is the fluorescence peak. For each peak,
k1/k2
assumes well defined values that were used to generate the curves drawn through the data in Fig. 1. All fluorescence traces are well described by the two-step model. The influence of suramin can be accounted for by
a successive reduction of k1 at a
constant value of k2. This agrees with
the model-independent evaluation of peak areas. At all suramin
concentrations tested, the data could be fitted with hydrolysis rates
of 0.044 s
1 < k2 < 0.059 s
1, which is in agreement with the range of
reported hydrolysis rates (Yamanaka et al., 1985
; Antonny et al., 1993
;
Otto-Bruc et al., 1994
) and renders unlikely denaturation of
Gt by suramin. In contrast,
k1 had to be reduced by factors of
0.85, 0.52, 0.38, and 0.14 in the presence of 3, 6, 12, and 24 µM
suramin, respectively, relative to its value in the absence of suramin.
Therefore, a pronounced influence is exerted on the reaction(s) that
lead to uptake of GTP by Gt, whereas an effect of
suramin on GTP hydrolysis (k2) must be
small, if it is present at all. The drop in
k1 for Gt
activation with GTP
S (k2 = 0)
parallels that for activation with GTP. For example, the
GTP
S-induced signal at 24 µM suramin (Fig. 1 D) is
approximated by the model when k1 is
reduced by the same factor (0.14) that was used for the simulation of
the GTP-induced signal.
In the measurements shown in Fig. 1, where [GTP] < [Gt], the reaction mixture had become depleted
of GTP before a steady state was reached during which GTP hydrolysis
can approximately balance the formation of
Gt
(GTP). At higher [GTP], a nearly constant fraction of Gt
(GTP) was present before the
pool of nucleotide was eventually turned over. This resulted in a
broadening of the fluorescence signal that cannot be reproduced by the
two-step reaction model. Fluorescence time courses with [GTP] > [Gt] (Fig. 2)
were analyzed in a more realistic model (Eqs. 2 and 3) to assess specifically the influence of suramin on MIIGt
formation (kc) and GTP uptake
(ku). The values for
ku and
kh in the absence of suramin were held
constant and only kc was varied. In an
iterative process, a pair of rate constants
ku and
kh was found that allowed simultaneous
fits of reasonable quality to all traces. At constant rates of
ku of 0.14 µM
1 s
1 and
kh of 0.031 s
1, kc was
reduced by factors of 0.43, 0.3, and 0.12 at 2.5, 5.0, and 10.0 µM
suramin, respectively, relative to its value of 0.7 µM
1 s
1 in the absence
of suramin. [GTP] was increased by 18% at 10 µM suramin (Fig. 2
D) to extend the steady state during which
[Gt
(GTP)] was only slowly changing. In
contrast to the two-step model, the three-step model is clearly able to
describe this situation. The rate constants for
MIIGt association and GTP hydrolysis in the absence of suramin are of the correct magnitude (Schleicher and Hofmann, 1987
; Yamanaka et al., 1985
; Antonny et al., 1993
; Otto-Bruc et al., 1994
), and we conclude that suramin acts primarily on kc. The additional curves in Fig. 2,
C and D (thin lines) were obtained by exclusively
adjusting ku. Obviously, the shape of the resulting time courses is incorrectly described, particularly at
high suramin concentrations. This supports a specific action of suramin
on MIIGt formation while other molecular
processes on the Gt activation/deactivation
pathway can proceed normally. In control experiments (Fig. 2,
E-G) in which heparin was substituted for
suramin, the fluorescence changes were not affected, ruling out a
general polyanionic effect on Gt activation. In
summary, the kinetic analyses reveal that suramin slows down the
light-dependent activation of Gt by reducing the
rate of MIIGt complex formation, whereas GTP
uptake and GTP hydrolysis is not affected.
|
Fluorescence energy transfer from Gt
to suramin
The reduction of both basal Gt fluorescence
and the GTP
S-induced fluorescence increase indicates that suramin
binds to Gt
, thereby quenching its tryptophan
fluorescence. The nucleotide-dependent fluorescence change of
Trp207 was more affected than basal fluorescence.
For example, basal fluorescence at 24 µM suramin was reduced by 50%,
whereas the GTP
S-induced fluorescence change was reduced by 70%
(Fig. 1, A and D). Quenching of
Gt
fluorescence was further analyzed by
fluorescence emission spectroscopy. When excited at 295 nm, Gt
fluorescence is maximal at 343 nm. With
increasing suramin concentration, fluorescence at this wavelength
decreased while emission from suramin above 400 nm increased (Fig.
3 A). At low suramin
concentrations and 240 nM Gt
, appearance of
suramin fluorescence was barely visible, whereas an isosbestic point
formed at 377 nm at suramin concentrations above 0.5 µM. The spectra indicate that Gt
and suramin form a
donor-acceptor pair undergoing FRET with spectral features almost
identical with those described for other suramin-binding proteins
(Mély et al., 1997
; Zhang et al., 1998
). At 480 nM
Gt
, formation of an isosbestic point at 416 nm
for suramin concentrations below 0.5 µM was reproducibly observed
(Fig. 3 B). The decrease of Gt
fluorescence between 10 and 53 µM suramin and the concomitant
increase of suramin fluorescence above 400 nm suggest that suramin
binds to Gt
with a
Kd > 10 µM. However, the insets in
Fig. 3 show that the fraction of free Gt
(Eq. 4) was barely changing above 5 µM suramin when corrected for
absorption of excitation and emission light by suramin (see Materials
and Methods). The corrected data reveal that suramin binds to
Gt
with a Kd
of ~0.5 µM, typical of suramin binding to other G-proteins
(Freissmuth et al., 1996
). The fluorescence increase above 400 nm
observed between 10 and 53 µM suramin was thus due to free suramin,
and the decrease of tryptophan emission was caused by absorption of
excitation light by suramin. This was expected as the amount of suramin
exceeded that of Gt
by a factor of 40-200,
implying preponderance of free suramin. Likewise, the upshift of the
apparent isosbestic point at [suramin] > 0.5 µM from 377 nm to 390 nm at 240 and 480 nM Gt
, respectively, is
entirely consistent with stronger tryptophan emission bands in Fig. 3
B versus A superimposed with directly excited
fluorescence from free suramin.
|
Influence of suramin on the structure of rhodopsin, MII, and MIIGt and on membrane anchoring of Gt
In addition to binding to Gt
, reduced
Gt activation may be caused by suramin shifting
the MI/MII equilibrium toward the inactive MI species. However,
UV-visible absorption changes did not show an absorption increase in
the 460-480-nm range (MI) at the expense of decreased 380-nm
absorption (MII, not shown). We have addressed more subtle effects of
suramin on the conformation of rhodopsin, MII, and
MIIGt by ATR-FTIR spectroscopy. Light-induced conformational changes in rhodopsin are accompanied by characteristic shifts in the frequencies of vibrational modes of the structurally affected parts of the protein backbone, amino acid side chains, and the
retinal chromophore as reviewed in Siebert (1995)
. Consequently, light-induced FTIR difference spectra allow the detection of
perturbations of the normal structural changes during MII formation. In
contrast to transmissive FTIR spectroscopy, the ATR-FTIR technique
applied here monitors absorption changes of disk membranes adsorbed on an internal reflection element (IRE) in the presence of a bulk aqueous
phase. In addition to structural changes, shifts in the binding
equilibrium between Gt or suramin in the aqueous
phase and in disk membranes give rise to IR-absorption changes as the amount of absorbing species in the evanescent field of the IRE (extending ~1 µm from its surface) is affected. IR absorption changes during MII formation at pH 5 are shown in Fig.
4 (negative bands are caused by the dark
state, and positive bands correspond to absorption by MII). Except for
a small additional positive band at 1040 cm
1,
typical of suramin (Fig. 4 E), no alterations were observed in the difference spectrum recorded at 50 µM suramin (Fig. 4
B) versus normal MII formation (Fig. 4 A),
although GTP-induced fluorescence signals were completely abolished at
this concentration. At 500 µM suramin (Fig. 4 C), the
light-induced absorption increase at 1040 cm
1
was larger, and additional alterations occurred in the amide I and II
spectral range. These were identified by subtracting the normal MII
difference spectrum from that measured in the presence of 500 µM
suramin, resulting in the spectrum shown in Fig. 4 D. The
flat baseline obtained between 1700 and 1800 cm
1 demonstrates that the C==O stretching
vibrations of Asp83 (1767(
)/1747(+)),
Glu113 (1711(+)), and
Glu122 (1727(
)/1747(+)) (Fahmy et al., 1993
;
Rath et al., 1993
; Jäger et al., 1994
) were not altered. This
confirms that the reduction of Gt activation
cannot be attributed to a stabilizing effect of suramin on the MI
state. A shift in the MI/MII equilibrium would have led to residual
bands between 1700 and 1800 cm
1 (Fahmy, 1998
)
caused by protonated Glu122 and by protonation of
Glu113 in MII. The absorption at 1040 cm
1 and the bands between 1400 and 1000 cm
1 correspond well with absorption by free
suramin (Fig. 4 E) and indicate binding of suramin to
photoactivated disk membranes. The alterations at 1650 and 1545 cm
1 may indicate an effect on the structure of
dark rhodopsin at 500 µM suramin (i.e., in excess of serum
concentrations of suramin in patients (Chaudhry et al., 1996
));
however, the band at 1643 cm
1, typical of the
Gt activating conformation of MII (Fahmy et al., 1994
; Zvyaga et al., 1996
), was not affected. In conclusion, the FTIR
difference spectra argue against structural perturbations of rhodopsin
or MII by suramin in the low micromolar range.
|
To study the influence of suramin on the structure of
MIIGt, Gt was added to disk
membranes in the dark. Binding of Gt is accompanied by characteristic absorption increases in the amide I
(1610-1700 cm
1) and II (1510-1580
cm
1) frequency range (Fig.
5 A) as
Gt accumulates in the evanescent field of the
IRE. The functionality of MII Gt interactions
under the conditions of the ATR-FTIR experiment has been demonstrated (Fahmy, 1998
). After illumination, suramin was added by dialysis and
ensuing absorption changes were recorded. Appearance of the drug in the
evanescent field was evidenced by the sharp absorption increase at 1040 cm
1 (Fig. 5 B). In the amide I and
II frequency range, slight absorption increases were observed as well
and may have been caused by the amide groups in suramin or additional
binding of Gt. More importantly, no negative
bands occurred. Such bands are expected when suramin caused
denaturation of MIIGt, thereby shifting
vibrational frequencies of structurally affected peptide bonds. If
suramin causes conformational changes in MIIGt at
all, they must be smaller than those accompanying the light-dependent
formation of MII or MIIGt, as these would clearly
be visible as sharp superimposed difference bands of 1-3 mAU in the
amide I/II range (Fahmy, 1998
). Likewise, suramin does not dissociate
MIIGt. As shown in Fig. 5 C,
dissociation of MIIGt upon addition of nucleotide
is not prevented either. GTP
S was added to the dialysis compartment
in a higher concentrated sodium phosphate buffer, providing a monitor
of the buffer exchange by the absorption increase of inorganic
phosphate at 1077 and 988 cm
1. The loss of
amide absorption of Gt coincided with the onset of absorption by inorganic phosphate, indicating that
Gt dissociated from disk membranes with the
arrival of the GTP
S-containing buffer in the evanescent field. The
ATR-FTIR results suggest that the reduction of the apparent rate of
Gt
(GTP) formation as determined by the
Gt activation assay is caused neither by a shift
in MI/MII equilibrium nor by altered structures of
MII/MIIGt, nor by occupation of the GTP-binding
site by suramin.
|
To test the influence of suramin on steps before
MIIGt formation, Gt was
allowed to bind to disk membranes in the dark (Fig. 6 A) and suramin was added
without prior photoactivation. With the arrival of suramin in the
evanescent field (1040 cm
1 absorption increase)
amide I and II absorption of Gt decreased. This
demonstrates that suramin promoted dissociation of
Gt from disk membranes. At 20 µM and 100 µM
suramin, ~60% and 85% of Gt absorption was
lost from the membranes, respectively. In a control experiment in which
suramin was replaced by 3-kDa heparin no loss of absorption by
Gt was observed (Fig. 6, D and
E). In summary, the ATR-FTIR data indicate that suramin
exerts its effect on signaling by rhodopsin through a loss of membrane
affinity of Gt rather than by affecting the
structure of rhodopsin, MII, MIIGt, or occupation of the GTP-binding site of Gt.
|
| |
DISCUSSION |
|---|
|
|
|---|
The influence of suramin on coupling of Gt to rhodopsin
We have demonstrated that pharmacologically relevant concentrations of suramin affect activation of Gt by bovine rhodopsin. This has made possible an analysis of the mechanism by which suramin acts on G-protein signaling in a well characterized in vitro model system. Kinetic analyses of Gt activation demonstrate that suramin affects coupling of Gt to MII but alters neither the rate of nucleotide uptake nor GTP hydrolysis. Likewise, neither the MI/MII equilibrium nor the structure of rhodopsin and MIIGt is altered by suramin at concentrations that abolish Gt activation. Instead, the rate of association of Gt with MII is reduced.
MIIGt formation exhibits a fast component
attributable to efficient collisions between MII and membrane-bound
Gt and a slow component for the transition of
Gt from a free to a disk-membrane-bound form
(Schleicher and Hofmann, 1987
). As membrane association is the
rate-limiting step, the influence of suramin can be explained by
inhibition of Gt binding to photoactivated disk
membranes. The molecular processes underlying this transition may be
very similar to or identical with those during association of
Gt with membranes in the dark. Thus,
suramin-induced dissociation of Gt from disk
membranes in the dark, evidenced by ATR-FTIR, may be directly related
to the mechanism by which MIIGt formation is impaired under conditions of multiple activation cycles. Because membrane anchoring of Gt is mediated by
Gt
(Seitz et al., 1999
), it is likely that
suramin perturbs the membrane attachment site on
Gt
. Binding of suramin to
Gt
is evidenced by FRET and is characterized
by a Kd of ~0.5 µM. The evaluation
of Gt activation rates is in general agreement
with this Kd. Even in the realm of a
simplified reaction model, including only GTP uptake and hydrolysis,
half-maximal inhibition occurred at 6 µM suramin, whereas 3 µM
would be expected from the estimated
Kd of 0.5 µM (conditions of the
experiment shown in Fig. 1). In a more realistic three-step model, 50%
reduction of the rate constant for MIIGt complex
formation was observed at 2.5 µM suramin concentration. This agrees
precisely with 50% saturation of suramin-binding sites with a
Kd of ~0.5 µM (conditions of the
experiment shown in Fig. 2) and strongly suggests that suramin binds in
a 1:1 stoichiometry to Gt
as reported for
binding to Gs
(Hohenegger et al., 1998
).
Half-maximal dissociation of Gt from disk
membranes measured by ATR-FTIR spectroscopy occurred at higher suramin
concentration (10-20 µM). Taking into account the different
experimental conditions, the concentrations for half-maximal effects of
suramin in both assays appear to be very similar. Therefore, our
data suggest that 1) occupation of a single suramin-binding site on
Gt
with Kd of
~0.5 µM is the predominant cause for the inhibition of
rhodopsin-catalyzed Gt activation, and 2) the
rate of complex formation between suramin-bound
Gt and MII is specifically impaired by a reduced
affinity of suramin-bound Gt
for photoreceptor membranes.
Reduction of membrane affinity of Gt
by
suramin may involve electrostatic repulsion of suramin-bound
Gt
(carrying six negative extra charges) from
disk membranes and/or interference with the exposure of the N-terminal
acyl chains. Results from SDS-PAGE of supernatants of
Gt-containing solutions (3 µM) equilibrated in
the dark with disk membranes agree with a reduced membrane affinity of
Gt in the presence of suramin (data not shown).
The same holds for binding of Gt to electrically
neutral phosphatidylcholine vesicles, rendering likely a specific
effect on lipid anchoring. The topology of the suramin-binding site on
Gt
needs further investigation, but one of the
two chromophoric 1,3,6-naphthalenetrisulfonate (NTS) moieties may bind
near Trp207. This is suggested by the
suramin-dependent reduction of nucleotide-induced fluorescence changes
of Gt
known to arise from
Trp207. Although binding of suramin to
nucleotide-binding sites has been described for other proteins (van
Rhee et al., 1994
; Khaled et al., 1995
), the different elution
properties of nucleotides versus suramin (Figs. 5 and 6) and the
unaltered rate constant for nucleotide uptake consistently disfavor
binding to the nucleotide-binding site of Gt.
Electrostatic interactions between NTS and positively charged amino
acids have been inferred from the solution structure of NTS-bound
acidic fibroblast growth factor (Lozano et al., 1998
) and may be
crucial for binding of NTS to Gt as well.
Preliminary docking simulations using the program FlexX provided by the
Gesellschaft für Mathematische Datenanalyse (Bonn, Germany), also
resulted in highest-scoring solutions for binding of NTS to
Gt
(Protein Data Bank entry 1TAD) in positions
within less than 3 Å from the positively charged guanidinium groups of
Arg201 and Arg204 and
10-15 Å apart from Trp207. We suspect that the
drug approaches the N-terminus of Gt
where it
may interfere with membrane anchoring (Matsuda et al., 1994
; Seitz et
al., 1999
) and may additionally affect electrostatically driven steps
during receptor recognition (Fanelli et al., 1999
).
Comparison with the action of suramin on other receptor G-protein tandems
Structural and functional properties are probably conserved among
members of each class of GPCRs. Two modes of action of suramin on
Gs-, Gi-, and
Go-dependent signaling by class I
(rhodopsin-like) GPCRs have been described. One mode is the reduction
of basal nucleotide exchange at submicromolar to micromolar
concentrations of suramin. We have shown here that suramin binds to
Gt
in a 1:1 stoichiometry as reported for
other G-proteins (Hohenegger et al., 1998
) and with a
Kd that falls in the same range as the EC50 for suppression of basal nucleotide
exchange. However, Gt does not exhibit
receptor-independent nucleotide exchange. Correspondingly, the
rhodopsin Gt model system was not expected to
respond to this particular mode of suramin action. Another mode of
suramin action is uncoupling from the receptor (Beindl et al., 1996
).
We have demonstrated that inhibition of rhodopsin-dependent
Gt activation does indeed occur. It has been
shown for Gs
that suramin binds not only to
epitopes involved in receptor recognition but also overlaps with
effector binding sites (Freissmuth et al., 1996
).
Trp207 in Gt
is near
switch II of Gt
and thus close to regions that
bind to the effector (Berlot and Bourne, 1992
; Rarick et al., 1992
).
Binding of suramin to that region would also be consistent with the
preferential quenching of fluorescence from
Trp207. Finally, binding of suramin to
Gi
/Gs
has been shown to cause dissociation of the ternary complex with agonist-bound receptors (Beindl et al., 1996
). Because the agonist of rhodopsin, all-trans retinal, is covalently bound, an analogous action
of suramin was not expected in this system, and dissociation of
MIIGt was not observed. This parallels the
quasi-competitive behavior of suramin with respect to agonist as
increasing receptor occupancy could reverse the destabilizing effect of
suramin on the ternary complex of ligand-activated receptors.
The action of suramin on signaling by other G-protein
-subunits appears to be paralleled by its action on
Gt when the unique features of this system are
taken into account. Our data further suggest that inhibition of
receptor-catalyzed G-protein activation may operate through a reduced
membrane affinity of suramin-bound G-protein
-subunits. Binding to
membranes is primarily mediated by G
-palmitoylation and
to a less extent by N-terminal myristoylation (as reviewed in
Wedegaertner et al., 1995
; Milligan and Grassie, 1997
).
Gt is not palmitoylated and may be particularly
sensitive to destabilization of membrane anchoring via a single
N-terminal acylation. However, G-protein palmitoylation is a dynamic
process. For example, palmitate turnover on Gs
in S49
cells has been shown to become accelerated upon
-adrenergic receptor
activation (Wedegaertner and Bourne, 1994
). Therefore, the acylation
state and, correspondingly, the membrane affinity of other
G
-subunits may transiently correspond with that of
Gt.
| |
CONCLUSIONS |
|---|
|
|
|---|
Rhodopsin Gt interactions may constitute a versatile in vitro model system to elucidate the action of suramin-related drugs on G-protein-dependent signaling. Furthermore, our results hint at a possible adverse effect on scotopic vision in patients receiving suramin treatment. Constant monitoring of dosage in these patients is important because of toxic effects of suramin. A putative impairment of rhodopsin-mediated dim light vision by suramin needs further investigation as it may correlate with other adverse effects that need to be controlled in clinical studies.
We thank Prof. T. P. Sakmar, in whose lab G.K.A. is a post-doctoral associate. We are also grateful to Prof. K. Vogt who generously provided the laboratory for K.F. at the Institut fuer Biologie I at University Freiburg. Furthermore, introduction to the program FlexX by Dr. G. Metz and excellent technical assistance from B. Mayer is gratefully acknowledged.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by Deutsche Forschungsgemeinschaft grant FA 248/4-1 to K.F.
| |
FOOTNOTES |
|---|
Address reprint requests to Dr. Karim Fahmy, Institut für Molekulare Medizin und Zellforschung, Universität Freiburg, Albertstrasse 23, D-79104 Freiburg, Germany. Tel.: 49-761-203-5380; Fax: 49-761-203-2921; E-mail: fahmy{at}uni-freiburg.de.
Submitted July 26, 2001, and accepted for publication October 1, 2001.
| |
REFERENCES |
|---|
|
|
|---|
.
Cell.
68:911-922
-selective G protein antagonists.
Proc. Natl. Acad. Sci. U.S.A.
95:346-351